Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 12Solid Tumor 9Solid Tumors 6Advanced Solid Tumors 5Advanced Solid Tumor 4Advanced Solid Tumour 2Solitary Fibrous Tumor, Pleural 1Solid Tumor Cancer 1Resectable Colon Cancer 1Mesothelioma, Malignant 1MSI-H Colorectal Cancer 1Locally Advanced and Metastatic Solid Tumors 1DMMR Colorectal Cancer 1Childhood Solid Tumor 1Advanced Solid Tumor Cancer 1Advanced Malignant Solid Tumors 1Adult 1

Interventions

ispinesib 2trifluridine tipiracil drug combination 1trametinib 1tipiracil 1irinotecan sucrosofate 1Vincristine 1Trifluridine 1Temozolomide 1TP protocol 1SB 743921 1Pemetrexed 1Paclitaxel 1PE regimen 1Interleukin-18 1Immunotherapy 1Imatinib Mesylate 1Exercise Therapy 1Docetaxel 1Cisplatin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor Cancer × Capecitabine × Other solid neoplasm × Clear all
NCT00119171 2008-10-16

Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

GlaxoSmithKline

Phase 1 Completed
30 enrolled
Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡